Zinc finger protein 337 (ZNF337) belongs to the zinc finger protein superfamily, which encompasses one of the largest classes of nucleic acid-binding proteins. ZNF337 is characterized by the presence of zinc finger domains, which are small protein structural motifs coordinated by zinc ions. These domains typically contain combinations of cysteine (C) and histidine (H) residues, often referred to as C2H2 zinc fingers, which form a finger-like loop stabilized by the zinc ion.The ZNF337 protein, through its zinc finger domains, is thought to function predominantly as a transcription factor. Transcription factors are integral to the regulation of gene expression, influencing a myriad of biological processes such as development, differentiation, proliferation, and apoptosis. By binding to specific DNA sequences, ZNF337 is presumed to control the transcriptional activity of various genes, serving as a molecular switch to modulate their expression.
While the specific target genes and regulatory pathways of ZNF337 are not fully delineated, zinc finger proteins are generally known to be versatile in their binding capabilities and can regulate diverse sets of genes. Some zinc finger proteins are also known to interact with RNA or mediate protein-protein interactions, expanding their potential functional repertoire.Alterations in ZNF337, like other zinc finger proteins, could have significant biological consequences. Mutations, abnormal expression levels, or dysregulation of such transcription factors can contribute to a range of pathological conditions, including developmental abnormalities and diseases such as cancer.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, potentially affecting gene expression patterns and indirectly influencing ZNF337 activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase (HDAC) inhibitor, which may alter chromatin structure and gene expression, potentially impacting ZNF337. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Another HDAC inhibitor, potentially affecting gene regulation and indirectly influencing ZNF337 activity. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $128.00 $505.00 | 2 | |
A DNA methyltransferase inhibitor, which can alter gene expression and potentially impact ZNF337. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to 5-Azacytidine, affects DNA methylation and gene expression, potentially influencing ZNF337. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $88.00 $208.00 | 24 | |
A selective HDAC inhibitor, which may have implications for gene regulation involving ZNF337. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
A BET bromodomain inhibitor, potentially influencing gene expression and regulatory mechanisms involving ZNF337. | ||||||
I-BET 151 Hydrochloride | 1300031-49-5 (non HCl Salt) | sc-391115 | 10 mg | $450.00 | 2 | |
Another BET bromodomain inhibitor, which can affect transcription regulation, potentially impacting ZNF337. | ||||||
A-366 | 1527503-11-2 | sc-507495 | 10 mg | $195.00 | ||
A G9a/GLP histone methyltransferase inhibitor, potentially altering epigenetic marks and gene expression relevant to ZNF337. | ||||||
UNC1999 | 1431612-23-5 | sc-475314 | 5 mg | $142.00 | 1 | |
A selective EZH2/EZH1 inhibitor, potentially affecting gene expression patterns relevant to ZNF337. |